PDCD1 and melanoma: Humanized monoclonal IgG4 anti-PD-1 antibody approved for the treatment of unresectable, metastatic or completely resected melanoma, metastatic NSCLC, urothelial carcinoma (UC), advanced RCC, HNSCC, cHL, CRC and HCC.